289 related articles for article (PubMed ID: 30254057)
1. Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells.
Foulkes DM; Byrne DP; Yeung W; Shrestha S; Bailey FP; Ferries S; Eyers CE; Keeshan K; Wells C; Drewry DH; Zuercher WJ; Kannan N; Eyers PA
Sci Signal; 2018 Sep; 11(549):. PubMed ID: 30254057
[TBL] [Abstract][Full Text] [Related]
2. Analysis of human Tribbles 2 (TRIB2) pseudokinase.
Harris JA; Fairweather E; Byrne DP; Eyers PA
Methods Enzymol; 2022; 667():79-99. PubMed ID: 35525562
[TBL] [Abstract][Full Text] [Related]
3. Tribbles pseudokinases: novel targets for chemical biology and drug discovery?
Foulkes DM; Byrne DP; Bailey FP; Eyers PA
Biochem Soc Trans; 2015 Oct; 43(5):1095-103. PubMed ID: 26517930
[TBL] [Abstract][Full Text] [Related]
4. Human TRIB2 Oscillates during the Cell Cycle and Promotes Ubiquitination and Degradation of CDC25C.
Liang KL; Paredes R; Carmody R; Eyers PA; Meyer S; McCarthy TV; Keeshan K
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563873
[TBL] [Abstract][Full Text] [Related]
5. TRIB2 and the ubiquitin proteasome system in cancer.
Salomè M; Campos J; Keeshan K
Biochem Soc Trans; 2015 Oct; 43(5):1089-94. PubMed ID: 26517929
[TBL] [Abstract][Full Text] [Related]
6. Tribbles breaking bad: TRIB2 suppresses FOXO and acts as an oncogenic protein in melanoma.
Link W
Biochem Soc Trans; 2015 Oct; 43(5):1085-8. PubMed ID: 26517928
[TBL] [Abstract][Full Text] [Related]
7. Impaired phosphorylation and ubiquitination by p70 S6 kinase (p70S6K) and Smad ubiquitination regulatory factor 1 (Smurf1) promote tribbles homolog 2 (TRIB2) stability and carcinogenic property in liver cancer.
Wang J; Zhang Y; Weng W; Qiao Y; Ma L; Xiao W; Yu Y; Pan Q; Sun F
J Biol Chem; 2013 Nov; 288(47):33667-33681. PubMed ID: 24089522
[TBL] [Abstract][Full Text] [Related]
8. Tribbles Pseudokinase 2 (TRIB2) Regulates Expression of Binding Partners in Bovine Granulosa Cells.
Warma A; Lussier JG; Ndiaye K
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546420
[TBL] [Abstract][Full Text] [Related]
9. Transformation by Tribbles homolog 2 (Trib2) requires both the Trib2 kinase domain and COP1 binding.
Keeshan K; Bailis W; Dedhia PH; Vega ME; Shestova O; Xu L; Toscano K; Uljon SN; Blacklow SC; Pear WS
Blood; 2010 Dec; 116(23):4948-57. PubMed ID: 20805362
[TBL] [Abstract][Full Text] [Related]
10. Trapping Tribbles: Nanobody-assisted structure of the TRIB2 pseudokinase.
Santana FR; Linossi EM; Jura N
Structure; 2022 Nov; 30(11):1465-1467. PubMed ID: 36332608
[TBL] [Abstract][Full Text] [Related]
11. Nanobodies identify an activated state of the TRIB2 pseudokinase.
Jamieson SA; Pudjihartono M; Horne CR; Viloria JS; Dunlop JL; McMillan HD; Day RC; Keeshan K; Murphy JM; Mace PD
Structure; 2022 Nov; 30(11):1518-1529.e5. PubMed ID: 36108635
[TBL] [Abstract][Full Text] [Related]
12. TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT.
Hill R; Madureira PA; Ferreira B; Baptista I; Machado S; Colaço L; Dos Santos M; Liu N; Dopazo A; Ugurel S; Adrienn A; Kiss-Toth E; Isbilen M; Gure AO; Link W
Nat Commun; 2017 Mar; 8():14687. PubMed ID: 28276427
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal regulation between O-GlcNAcylation and tribbles pseudokinase 2 (TRIB2) maintains transformative phenotypes in liver cancer cells.
Yao B; Xu Y; Wang J; Qiao Y; Zhang Y; Zhang X; Chen Y; Wu Q; Zhao Y; Zhu G; Sun F; Li Z; Yuan H
Cell Signal; 2016 Nov; 28(11):1703-12. PubMed ID: 27515988
[TBL] [Abstract][Full Text] [Related]
14. TRIB2 inhibits Wnt/β-Catenin/TCF4 signaling through its associated ubiquitin E3 ligases, β-TrCP, COP1 and Smurf1, in liver cancer cells.
Xu S; Tong M; Huang J; Zhang Y; Qiao Y; Weng W; Liu W; Wang J; Sun F
FEBS Lett; 2014 Nov; 588(23):4334-41. PubMed ID: 25311538
[TBL] [Abstract][Full Text] [Related]
15. Tribbles 2 (Trib2) is a novel regulator of toll-like receptor 5 signaling.
Wei SC; Rosenberg IM; Cao Z; Huett AS; Xavier RJ; Podolsky DK
Inflamm Bowel Dis; 2012 May; 18(5):877-88. PubMed ID: 22271508
[TBL] [Abstract][Full Text] [Related]
16. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers.
Roskoski R
Pharmacol Res; 2019 Jan; 139():395-411. PubMed ID: 30500458
[TBL] [Abstract][Full Text] [Related]
17. Tribbles in the 21st Century: The Evolving Roles of Tribbles Pseudokinases in Biology and Disease.
Eyers PA; Keeshan K; Kannan N
Trends Cell Biol; 2017 Apr; 27(4):284-298. PubMed ID: 27908682
[TBL] [Abstract][Full Text] [Related]
18. Daclatasvir, an Antiviral Drug, Downregulates Tribbles 2 Pseudokinase and Resensitizes Enzalutamide-Resistant Prostate Cancer Cells.
Monga J; Valeriote F; Hwang C; Gadgeel S; Ghosh J
Mol Cancer Ther; 2023 Mar; 22(3):381-392. PubMed ID: 36805730
[TBL] [Abstract][Full Text] [Related]
19. Tribbles 2 mediates cisplatin sensitivity and DNA damage response in epithelial ovarian cancer.
Kritsch D; Hoffmann F; Steinbach D; Jansen L; Mary Photini S; Gajda M; Mosig AS; Sonnemann J; Peters S; Melnikova M; Thomale J; Dürst M; Runnebaum IB; Häfner N
Int J Cancer; 2017 Oct; 141(8):1600-1614. PubMed ID: 28670762
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of TRIB2 in human lung cancers contributes to tumorigenesis through downregulation of C/EBPα.
Grandinetti KB; Stevens TA; Ha S; Salamone RJ; Walker JR; Zhang J; Agarwalla S; Tenen DG; Peters EC; Reddy VA
Oncogene; 2011 Jul; 30(30):3328-35. PubMed ID: 21399661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
